Other congenital malaria
ICD-10 P37.4 is a billable code used to indicate a diagnosis of other congenital malaria.
Congenital malaria is a rare but serious condition resulting from the transmission of malaria parasites from an infected mother to her fetus during pregnancy. This condition can lead to severe complications in newborns, including low birth weight, anemia, and respiratory distress. The most common malaria parasite involved is Plasmodium falciparum, but other species can also be implicated. Newborns may present with symptoms such as fever, jaundice, and splenomegaly shortly after birth. Diagnosis is typically made through blood smears or rapid diagnostic tests. Treatment involves antimalarial medications, and early intervention is crucial to prevent long-term sequelae. Other congenital infectious diseases, such as congenital tuberculosis and toxoplasmosis, can present similarly, necessitating careful differential diagnosis. Congenital tuberculosis may lead to respiratory issues and systemic infection, while toxoplasmosis can cause neurological deficits and ocular problems. Understanding the clinical presentation and management of these conditions is essential for effective neonatal care.
Detailed documentation of clinical findings, maternal history, and treatment protocols.
Newborns presenting with fever and jaundice in the NICU.
Close monitoring for complications such as anemia and respiratory distress.
Comprehensive pediatric assessments including developmental milestones and follow-up care.
Pediatric follow-up for infants diagnosed with congenital malaria.
Awareness of potential long-term effects on growth and development.
Used for blood tests to confirm congenital malaria diagnosis.
Document the reason for blood draw and any relevant clinical findings.
Neonatologists should ensure accurate lab results are linked to the diagnosis.
Common symptoms include fever, jaundice, anemia, and splenomegaly. Early recognition and treatment are crucial to prevent complications.
